Fortune Rock   Report issue

For profit Phase 1 Phase 2
Founded: Beijing China (1993)
Status: No NME R&D (1993)

Organization Overview

First Clinical Trial
2012
NCT01919710
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

Beijing Bio-Fortune Ltd. | Tianjin SinoBiotech Ltd.